Indian pharma companies Dr. Reddy's, Sun Pharma, and Aurobindo voluntarily recall US products due to manufacturing issues; FDA classifies recalls as Class I or II.
Indian pharmaceutical companies Dr. Reddy's, Sun Pharma, and Aurobindo Pharma are voluntarily recalling their products in the US due to manufacturing issues. Dr. Reddy's Laboratories is recalling Javygtor due to sub-potency, Sun Pharma is recalling Amphotericin B Liposome for Injection due to being "Out of Specification for Assay," and Aurobindo Pharma is recalling Clorazepate Dipotassium Tablets due to discoloration. The US Food and Drug Administration (FDA) has classified these recalls as Class I (potentially serious health risks) and Class II (temporary or medically reversible adverse health consequences).
May 19, 2024
8 Articles